mTOR signalling pathway in stem cell bioactivities and angiogenesis potential
- PMID: 37156724
- PMCID: PMC10693190
- DOI: 10.1111/cpr.13499
mTOR signalling pathway in stem cell bioactivities and angiogenesis potential
Abstract
The mammalian target of rapamycin (mTOR) is a protein kinase that responds to different stimuli such as stresses, starvation and hypoxic conditions. The modulation of this effector can lead to the alteration of cell dynamic growth, proliferation, basal metabolism and other bioactivities. Considering this fact, the mTOR pathway is believed to regulate the diverse functions in several cell lineages. Due to the pleiotropic effects of the mTOR, we here, hypothesize that this effector can also regulate the bioactivity of stem cells in response to external stimuli pathways under physiological and pathological conditions. As a correlation, we aimed to highlight the close relationship between the mTOR signalling axis and the regenerative potential of stem cells in a different milieu. The relevant publications were included in this study using electronic searches of the PubMed database from inception to February 2023. We noted that the mTOR signalling cascade can affect different stem cell bioactivities, especially angiogenesis under physiological and pathological conditions. Modulation of mTOR signalling pathways is thought of as an effective strategy to modulate the angiogenic properties of stem cells.
© 2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis.Life Sci. 2023 Jun 15;323:121662. doi: 10.1016/j.lfs.2023.121662. Epub 2023 Apr 5. Life Sci. 2023. PMID: 37028545 Review.
-
Mammalian target of rapamycin: a central node of complex signaling cascades.Int J Clin Exp Pathol. 2011 Jun 20;4(5):476-95. Epub 2011 Jun 14. Int J Clin Exp Pathol. 2011. PMID: 21738819 Free PMC article. Review.
-
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.Acta Physiol (Oxf). 2009 May;196(1):65-80. doi: 10.1111/j.1748-1716.2009.01972.x. Epub 2009 Feb 19. Acta Physiol (Oxf). 2009. PMID: 19245654 Free PMC article. Review.
-
An emerging role for TOR signaling in mammalian tissue and stem cell physiology.Development. 2011 Aug;138(16):3343-56. doi: 10.1242/dev.058230. Development. 2011. PMID: 21791526 Free PMC article. Review.
-
Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism.Biochem J. 2004 Jun 15;380(Pt 3):795-804. doi: 10.1042/BJ20040274. Biochem J. 2004. PMID: 15030312 Free PMC article.
Cited by
-
Multi-Omics Approaches for Liver Reveal the Thromboprophylaxis Mechanism of Aspirin Eugenol Ester in Rat Thrombosis Model.Int J Mol Sci. 2024 Feb 10;25(4):2141. doi: 10.3390/ijms25042141. Int J Mol Sci. 2024. PMID: 38396823 Free PMC article.
-
mTOR Dysregulation, Insulin Resistance, and Hypertension.Biomedicines. 2024 Aug 8;12(8):1802. doi: 10.3390/biomedicines12081802. Biomedicines. 2024. PMID: 39200267 Free PMC article. Review.
References
-
- Ghosh P, Alam N, Mandal S, Mustafi SM, Murmu N. Association of mTOR pathway with risk of gastric cancer in male smoker with potential prognostic significance. Mol Biol Rep. 2020;47(10):7489‐7495. - PubMed
-
- Seetharaman R, Mahmood A, Kshatriya P, Patel D, Srivastava A. An overview on stem cells in tissue regeneration. Curr Pharm Des. 2019;25(18):2086‐2098. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous